GlassScriptPhysician profile
Heather Lecomte Joslin
NPI 1669941928
$6,097.23
in general payments reported to CMS, 2019-2025
29 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $990 · 2022: $1,746 · 2023: $1,213 · 2024: $1,042 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,336 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,336.36 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,628.98 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,506.41 | 2021-2025 | |
| Lilly USA, LLC | $711.79 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $376.47 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Allergan, INC. | $302.21 | 2022 | |
| Pfizer INC. | $258.02 | 2021-2025 | |
| Glaxosmithkline, LLC. | $195.18 | 2022-2024 | Arexvy |
| Biohaven Pharmaceuticals, INC. | $136.45 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $130.03 | 2022 | |
| Grt US Holding, INC. | $127.31 | 2022 | |
| Boston Scientific Corporation | $97.72 | 2023 | Wavewriter Alpha Prime 16 |
| Horizon Therapeutics Plc | $79.89 | 2021-2022 | |
| Amarin Pharma, INC. | $79.28 | 2021 | |
| Corium, LLC | $76.95 | 2024 | Azstarys |
| Currax Pharmaceuticals LLC | $57.70 | 2021-2023 | Nexletol, Contrave |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $56.39 | 2022-2023 | Quviviq |
| Hologic Sales and Service, LLC | $35.79 | 2024 | Aptima, Thinprep 2000 Processor |
| Amgen INC. | $33.42 | 2021-2022 | |
| Exact Sciences Corporation | $33.01 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ani Pharmaceuticals, INC. | $20.61 | 2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $20.41 | 2025 | Symbravo |
| Nestle Healthcare Nutrition INC. | $20.27 | 2022 | |
| Scilex Pharmaceuticals INC. | $19.87 | 2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.63 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.25 | 2022 | |
| Almatica Pharma LLC | $15.71 | 2022 | |
| Aimmune Therapeutics, INC. | $14.86 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $14.18 | 2022 | |
| Hikma Pharmaceuticals USA | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Joslin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.